A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)
Trial status:Recruiting
Trial ID:
R2810-ONC-2045
NCT ID:
EudraCT ID:
Sponsor:
The sponsor of a clinical trial is the company, institution or individual that takes responsibility for initiating, managing, and/or financing a clinical investigation. BioNTech collaborates with other pharmaceutical companies or institutions (collaborators) to develop certain new medicines. In particular cases BioNTech's collaborators are leading specific clinical trials and are acting as sponsors accordingly.
Regeneron Pharmaceuticals
Recruiting
Trial Details
This study is researching an investigational drug, called BNT116, in combination with cemiplimab. BNT116 and cemiplimab will each be called a "study drug", and together be called "study drugs". The study is focused on patients who have advanced non-small cell lung cancer (NSCLC).
The aims of this study are to see how safe and tolerable BNT116 is in combination with cemiplimab and to see how effective BNT116 in combination with cemiplimab is compared to cemiplimab by itself at treating cancer.
The study is looking at several other research questions, including:
- What side effects may happen from receiving the study drugs
- How much study drug is in the blood at different times
- Whether the body makes antibodies against the study drug(s) (which could make the drug less effective or could lead to side effects)
Medical Condition
Trial Drug
See more
Phase
Phase 2
Type
Interventional
Estimated Enrolment
100
Estimated Trial Date
Apr 2023 - Mar 2027
Trial Participant Requirements
Age
18+ years
Sex
Female & Male
Healthy Volunteers
No
Trial Locations
Location
Status
Location
The Oncology Institute of Hope and Innovation
Los Angeles, California, United States, 90033
Status
Recruiting
Location
University of California Irvine
Orange, California, United States, 92697
Status
Withdrawn
Location
UCLA Medical Center
Santa Monica, California, United States, 90095
Status
Recruiting
Location
Norton Cancer Institute, Downtown
Louisville, Kentucky, United States, 40202
Status
Recruiting
Location
Dana Farber/Harvard Cancer Center
Boston, Massachusetts, United States, 02215
Status
Terminated
Location
San Juan Oncology Associates
Farmington, New Mexico, United States, 87401
Status
Recruiting